A PAF receptor antagonist inhibits acute airway inflammation and late-phase responses but not chronic airway inflammation and hyperresponsiveness in a primate model of asthma
We have examined the effects of a PAF receptor antagonist, WEB 2170, on several indices of acute and chronic airway inflammation and associated changes in lung function in a primate model of allergic asthma. A single oral administration WEB 2170 provided dose related inhibition of the release of leu...
Saved in:
Main Authors: | R. H. Gundel (Author), C. D. Wegner (Author), H. O. Heuer (Author), L. G. Letts (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
1992-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Is platelet activating factor (PAF) an important mediator in bronchial asthma?
by: R. H. Gundel, et al.
Published: (1992) -
Stigmasterol alleviates allergic airway inflammation and airway hyperresponsiveness in asthma mice through inhibiting substance-P receptor
by: Jimei Zhang, et al.
Published: (2023) -
In mouse model of mixed granulocytic asthma with corticosteroid refractoriness, Bronchom mitigates airway hyperresponsiveness, inflammation and airway remodeling
by: Acharya Balkrishna, et al.
Published: (2024) -
Zinc supplementation alters airway inflammation and airway hyperresponsiveness to a common allergen
by: Morgan Carrie I, et al.
Published: (2011) -
Tomatidine Attenuates Airway Hyperresponsiveness and Inflammation by Suppressing Th2 Cytokines in a Mouse Model of Asthma
by: Chieh-Ying Kuo, et al.
Published: (2017)